Whether inhibition of H6PD might substantially suppress glycolysis in breast tumors and inhibit cancer progression remains unclear, and a detailed analysis of the impact of H6PD on energy metabolism as well as on redox regulation is required for a better understanding of the role of this enzyme in modulating cancer progression. The gene discussed is H6PD; the disease is cancer.